SIVE#106
Thesis
NASDAQ uplisting catalyst with US CHIPS act support, US cap table/ownership, larger valuation premiums, and M&A opportunities. Swedish media disinformation creating opportunity.
Original post text
I think SIVE should just become a full American company, and use NASDAQ listing as the first step. > US cap table / large ownership + US CHIPS act support already > larger valuation premiums + M&A opportunities. > local Swedish media blatant disinformation from underwater
🐂 Bull Case
- NASDAQ listing opens access to US institutional investors → massive demand pool that currently cannot easily buy Swedish-listed stock
- US CHIPS Act eligibility → potential government subsidies and contracts worth hundreds of millions
- M&A premium: as a US-listed entity, strategic acquirers (AVGO, MRVL, INTC) can more easily bid → takeout premium 30-50%
🐻 Bear Case
- Uplisting timeline uncertain — Swedish regulatory and corporate structure complexity could delay indefinitely
- Media disinformation campaigns create headline risk → retail sentiment whipsaws
- Debt-to-equity at 19x — leveraged balance sheet limits financial flexibility for US expansion
🚫 Invalidation
NASDAQ uplisting does not materialize within 6 months, or US CHIPS Act funding is redirected away from photonics
Break Conditions
- NASDAQ uplisting application is denied or delayed beyond Q4 2026
- Swedish regulatory intervention blocks corporate restructuring
Price Tracking
| Label | Ticker | Price | Recorded |
|---|---|---|---|
| t+3d | SIVE | $78.80 | 2026-06-05 18:35:52 |
Metadata
T0 Price: $68.95
Created: 2026-05-31 18:32:52
Scored: 2026-05-31T18:34:50.984899+00:00
Updated: 2026-06-05T18:35:52.244075+00:00